Home » EU Fines Astra 60 Million Euros for Blocking Generics
EU Fines Astra 60 Million Euros for Blocking Generics
European antitrust authorities fined AstraZeneca Plc 60 million euros ($73 million) on Wednesday for blocking generic competition to ulcer drug Losec, but said its excess profits dwarfed the penalty. The European Commission, which conducted a six-year investigation into the company's actions, said AstraZeneca had abused its dominant market position and misused the patent system to protect Losec between 1993 and 2000.
()a href="http://go.reuters.com/newsArticle.jhtml?type=topNews&storyID=8798961" target="_blank">Reuters
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May